1.Enabling greater private sector participation in health research in the Philippines.
Melanio U MARICIO ; Maria Angeli C MAGDARAOG ; Kristine Mae P MAGTUBO ; Lester Sam A GEROY
Acta Medica Philippina 2019;53(3):272-278
OBJECTIVE: This study reviewed the current health research and development environment in the Philippines with respect to the engagement between the public and private sectors. The overall objective was to identify the role of the private sector in health research and identify barriers and opportunities for successful public-private health research partnerships.
METHODS: Key informant interviews were conducted using a semi-structured interview tool. Secondary data such as annual reports and project funding documents from the Philippine Council for Health Research and Development were also analyzed.
RESULTS: The roles of the private sector when engaging with the public sector for research and development were identified as generators, funders, and adopters of research. Information gathered showed that there were several institutional and practice barriers to the successful collaboration of the public and private sectors, however there were also lessons learned from the successes of cases such as the Axis-Knee System, Sambong, and Lagundi technologies.
CONCLUSION: The collaboration and partnership of the public and private sectors can be mutually beneficial. Government initiative to increase the ease of collaboration with the private sector in health research was found to be a necessary step to stimulate a productive health research environment.
Private Sector ; Public-Private Sector Partnerships
2.Study on medical service supply public-private partnership mode: based on the view of public economics.
Journal of Central South University(Medical Sciences) 2015;40(2):214-221
Due to the quasi-public attributes of medical service, the supply mode and system could influence equity and fairness of general people's health. Based on the view of public economics, the purpose of this paper was to explain the economic nature of medical service supply. By analyzing the practice of public-private partnership (PPP) mode in medical care supply and the related public economic issues, we summarized the feasibility and risks of PPP model in Chinese medical care supply market. Finally, we discussed the innovative medical service system provided by government, public hospitals, and social capitals together. Therefore, to guarantee further development of this new medical service supply--PPP mode, we should pay attention to some practical problems, such as the share of cooperation cost and the balance between the benefit and risk among all partners.
China
;
Delivery of Health Care
;
organization & administration
;
Models, Economic
;
Public-Private Sector Partnerships
;
economics
3.Validation of the selection process of PhilHealth sponsored members in 4 barangays in a municipality in Batangas using the participatory action research
Salvador Vincent Bryan DG ; Paterno Ramon P ; Regalado-Paterno Elizabeth C ; San Juan Michael D ; Sabalo Ma. Angeli B ; Saceda Sylvette A ; Pineda Carminda J ; Unson Enrique Miguel S ; Taveros Mel Clark R ; Sales Cecille Marie C ; Puzon Gretel B ; Rafael Tonilene E ; Permites Abel Santini G
Acta Medica Philippina 2012;46(1):4-13
Objective. The present study aims to correlate the LGU list of PhilHealth Sponsored Members in a municipality of Batangas with the list of poor residents as identified by the Participatory Action Research (PAR) methodology.
Method. Interview of key informants documented the processes utilized by the LGU in determining PhilHealth beneficiaries for the Sponsored Program and the Participatory Action Research (PAR) survey in the classification of households into poor, middle and rich in four barangays of the municipality. The list of LGU Sponsored members was then cross matched with the PAR household classification.
Results. The comparison of the LGU list of Sponsored members and the household classification by the PAR survey showed a wide discrepancy: (1) 464 "Not Found" Sponsored households or 70% of the LGU's Sponsored list; (2) inclusion of the non-poor: 140 middle class families as classified by the PAR survey or 21.1% of the LGU's Sponsored list; and (3) exclusion of 413 or 87.5% of true poor families identified by the PAR Survey. Only 59 families or 8.9% of the LGU Sponsored list were classified as poor families by PAR.
Conclusion. PAR offers communities, LGUs and the National Health Insurance Program a tool to validate the coverage of the Sponsored program. LGUs and the PhilHealth should consider such tool or similar tools to validate their identification, selection and enrollment of the poor, which is extremely vital in achieving universal coverage. Given the right tool, communities are in the best position to identify the poor for the Sponsored program. By way of collaboration with the underprivileged themselves, the academe has a role in assisting communities in acquiring collective awareness of their own situation and developing capacity for improving their lives. The academe also has a role in assisting LGUs in improving their health systems and national health programs in validating and improving their implementation. Further studies should be done to investigate the following: the identity of the "not found" SP members; the utilization of PhilHealth benefits by the poor; and the prospect of utilizing the PAR method by other non-academic institutions in monitoring the progress of community programs.
Human
;
Male
;
Female
;
PUBLIC-PRIVATE SECTOR PARTNERSHIPS
;
HEALTH SERVICES
;
INSURANCE, HEALTH
;
HEALTH CARE ECONOMICS AND ORGANIZATIONS
;
ECONOMICS
;
FINANCING, ORGANIZED
;
INSURANCE
4.Challenges and strategies of drug innovation.
Acta Pharmaceutica Sinica 2013;48(7):1031-1040
Drug research involves scientific discovery, technological inventions and product development. This multiple dimensional effort embodies both high risk and high reward and is considered one of the most complicated human activities. Prior to the initiation of a program, an in-depth analysis of "what to do" and "how to do it" must be conducted. On the macro level, market prospects, capital required, risk assessment, necessary human resources, etc. need to be evaluated critically. For execution, drug candidates need to be optimized in multiple properties such as potency, selectivity, pharmacokinetics, safety, formulation, etc., all with the constraint of finite amount of time and resources, to maximize the probability of success in clinical development. Drug discovery is enormously complicated, both in terms of technological innovation and organizing capital and other resources. A deep understanding of the complexity of drug research and our competitive edge is critical for success. Our unique government-enterprise-academia system represents a distinct advantage. As a new player, we have not heavily invested in any particular discovery paradigm, which allows us to select the optimal approach with little organizational burden. Virtue R&D model using CROs has gained momentum lately and China is a global leader in CRO market. Essentially all technological support for drug discovery can be found in China, which greatly enables domestic R&D efforts. The information technology revolution ensures the globalization of drug discovery knowledge, which has bridged much of the gap between China and the developed countries. The blockbuster model and the target-centric drug discovery paradigm have overlooked the research in several important fields such as injectable drugs, orphan drugs, and following high quality therapeutic leads, etc. Prejudice against covalent ligands, prodrugs, nondrug-like ligands can also be taken advantage of to find novel medicines. This article will discuss the current challenges and future opportunities for drug innovation in China.
Academies and Institutes
;
Biomedical Research
;
China
;
Drug Costs
;
Drug Design
;
Drug Discovery
;
economics
;
Industry
;
economics
;
Investments
;
economics
;
Orphan Drug Production
;
Public-Private Sector Partnerships
5.Experts' perspectives on the application of public-private partnership policy in prevention of road traffic injuries.
Saber AZAMI-AGHDASH ; Homayoun SADEGHI-BAZARGANI ; Mohammad SAADATI ; Mohammad MOHSENI ; Hojatolah GHARAEE
Chinese Journal of Traumatology 2020;23(3):152-158
PURPOSE:
Successful application experiences on public-private partnership (PPP) in different countries, suggest that PPP could be an option in road traffic injury (RTI) prevention. The present study aims at investigating the applicability of PPP policy in RTI prevention in Iran based on the experts' perspectives.
METHODS:
This is a qualitative study with grounded theory approach which has been conducted in Tabriz University of Medical Sciences, Iran in 2018. The participants were 22 experts in the field of RTIs selected using purposive sampling method. Data were collected by semi-structured interviews and analyzed with content-analysis method.
RESULTS:
The results were classified under 5 main themes (applicability, scopes and services, challenges, advantages, and strategies) for applying PPP policy and 37 sub-themes. Due to the prevalence of RTIs, the present challenges in public sector, existence of qualified private sector, and successful experiences in other areas, there are opportunities for private sector partnership in prevention of RTIs. Private sector could participate in different scopes and services regarding RTI prevention, including road construction and maintenance, maintenance and provision of vehicles safety and public education. The main challenges including legislation issues, ambiguities in collaboration, political and organizational unsustainability, government's financial hardship and lack of experienced experts in the field of RTI. However, there are significant advantages including high efficiency in program implementation, covering the weaknesses of public sector, effective and efficient management on application of PPP in RTI prevention. The strategies include identifying and prioritizing the assignable activities, identifying the qualified private sector, developing PPP policies and legal frameworks, creating a common language between public and private parties, trying to meet the expectations of the private sector by public sector, developing a comprehensive and sound contract, and cultivating public culture to accept private sector in the field of RTI prevention.
CONCLUSION
This study sought to determine whether PPP could be used as strategy to reduce the burden of RTIs in Iran. But it requires a lot of preliminary studies to provide the context and conditions for applying this policy.
Accidental Injuries
;
prevention & control
;
Accidents, Traffic
;
prevention & control
;
Adult
;
Expert Testimony
;
Female
;
Humans
;
Iran
;
Male
;
Middle Aged
;
Public-Private Sector Partnerships
;
organization & administration
;
Qualitative Research
6.What Strategy Can be Applied to the Patients with Culture Positive Tuberculosis to Reduce Treatment Delay in a Private Tertiary Healthcare Center?.
Ji Eun LEE ; Yang Ki KIM ; Tae Hyong KIM ; Kyung Ha KIM ; Eun Jung LEE ; Soo Taek UH ; Tae Youn CHOI
Infection and Chemotherapy 2011;43(1):42-47
BACKGROUND: The contribution of the private sector to the treatment of tuberculosis (TB) is getting larger, and the private sector pays more attention to individualized, intensive care than patient monitoring or education, which would improve the microbiological cure rate or at least completion of treatment. We aim in this paper to assess the impact of the improved monitoring of patient on the treatment outcome in the private tertiary healthcare center. MATERIALS AND METHODS: We compared the data of the positive sputum cultures for TB from March 1, 2003 to March 31, 2006 (37 months) with that data from July 1, 2007 to August 31, 2008 (14 months) in single private tertiary healthcare center in the Republic of Korea (ROK). In the latter period, we notified physicians of the new culture-confirmed cases via a cellular phone short-massage-service (SMS) to prevent delayed recognition of positive cultures and we gave calls to patients to encourage treatment adherence and to complete the whole schedule of medication. RESULTS: After the intervention, initiation of anti-TB medication increased from 86.3% to 94.5% (P<0.05), the interval to medication from the first culture results was shortened from 22.9 days to 5.6 days (P=0.19) and the rate of treatment complication increased from 57.4% to 68.1% (P<0.01). CONCLUSION: Our results showed a possible strategy to improve the completion of treatment in a university hospital. Health care providers in the private sector should to improve success by better notification and monitoring in addition to their existing advanced medical resources.
Appointments and Schedules
;
Cellular Phone
;
Critical Care
;
Health Personnel
;
Humans
;
Monitoring, Physiologic
;
Mycobacterium tuberculosis
;
Nontuberculous Mycobacteria
;
Private Sector
;
Public-Private Sector Partnerships
;
Republic of Korea
;
Sputum
;
Tertiary Healthcare
;
Treatment Outcome
;
Tuberculosis
7.A Modern History of ‘Imperial Medicine’ Surrounding Hansen's Disease: Strategies to Manage Public Opinion in Modern Japanese Media.
Korean Journal of Medical History 2017;26(3):417-454
The purpose of this study is to understand the reality of imperial medicine by exploring the strategic attitude of the Japanese authority targeting the public who were not patients of Hansen's disease. For this purpose, this study examines the mass media data related to Hansen's disease published in Korea and Japan during the Japanese colonial rule. Research on Hansen's disease can be divided into medical, sociohistorical, social welfare, and human rights approach. There are medical studies and statistics on the dissemination of medical information about Hansen's disease and management measures, the history of the management of the disease, guarantee of the rights of the patients and the welfare environment, and studies on the autobiographical, literary writings and oral statements on the life and psychological conflicts of the patients. Among existing research, the topics of the study on Hansen's disease under the Japanese colonial rule include the history of the Sorokdo Island Sanatorium, investigation on the forced labor of the patients in the island, human rights violations against the patients, oral memoirs of the patients and doctors who practiced at that time. All of these studies are important achievements regarding the research on the patients. An important study of Hansen's disease in modern Japan is the work of Hujino Utaka, which introduces the isolation of and discrimination against the patients of Hansen's disease. Hujino Utaka's study examines the annihilation of people with infectious diseases in Japan and its colonies by the imperial government, which was the consequence of the imperial medical policies, and reports on the isolation of Hansen's disease patients during the war. Although these researches are important achievements in the study of Hansen's disease in modernity, their focus has mainly been on the history of isolation and exploitation in the Sorokdo Island Sanatorium and discrimination against the patients within the sanatorium, which was controlled by the director of the sanatorium. Consequently, the research tends to perceive the problem within the frame of antagonism between the agent of imperialism and the victims of exploitation by the hands of imperialism. Hence, it has limitations in that it has not fully addressed the problem of the people who were not Hansen's disease patients and as such, existed somewhere in between the two extremes in the process of administering medicine under the imperial rule. The purpose of this study is to identify the direction of imperial medicine in the history of Hansen's disease in Japan and to comprehend the characteristics of policy on Hansen's disease developed by Mitsuda Kensuke, who was behind the policy of imperial medicine, and examine the process of imperial medicine reaching out to the people (of Japan and its colonies). To achieve the goal, this study explores how the agent of imperial medicine gain the favor the public, who are not Hansen's disease patients, by means of the mass media. Specifically, this paper examines data in the Japanese language related to Korean patients of Hansen's disease including the mass media data on Hansen's disease in the source book titled The Collection of Data on Hansen's Disease in Joseon under the Colonial Rule(8 volumes) compiled by Takio Eiji, which has not been studied until now. It also reviews the cultural and popular magazines published in Japan and Joseon at that time.
Asian Continental Ancestry Group*
;
Communicable Diseases
;
Discrimination (Psychology)
;
Hand
;
History, Modern 1601-*
;
Human Rights
;
Humans
;
Japan
;
Korea
;
Leprosy*
;
Mass Media
;
Periodicals as Topic
;
Public Opinion*
;
Public-Private Sector Partnerships
;
Social Welfare
8.Vaccines today, vaccines tomorrow: a perspective.
Clinical and Experimental Vaccine Research 2013;2(1):4-7
Vaccines are considered as one of the major contributions of the 20th century and one of the most cost effective public health interventions. The International Vaccine Institute has as a mission to discover, develop and deliver new and improved vaccines against infectious diseases that affects developing nations. If Louis Pasteur is known across the globe, vaccinologists like Maurice Hilleman, Jonas Salk and Charles Merieux are known among experts only despite their contribution to global health. Thanks to a vaccine, smallpox has been eradicated, polio has nearly disappeared, Haemophilus influenzae B, measles and more recently meningitis A are controlled in many countries. While a malaria vaccine is undergoing phase 3, International Vaccine Institute, in collaboration with an Indian manufacturer has brought an oral inactivated cholera vaccine to pre-qualification. The field of vaccinology has undergone major changes thanks to philanthropists such as Bill and Melinda Gates, initiatives like the Decade of Vaccines and public private partnerships. Current researches on vaccines have more challenging targets like the dengue viruses, malaria, human immunodeficiency virus, the respiratory syncytial virus and nosocomial diseases. Exciting research is taking place on new adjuvants, nanoparticles, virus like particles and new route of administration. An overcrowded infant immunization program, anti-vaccine groups, immunizing a growing number of elderlies and delivering vaccines to difficult places are among challenges faced by vaccinologists and global health experts.
Cholera
;
Communicable Diseases
;
Cooperative Behavior
;
Dengue Virus
;
Developing Countries
;
Haemophilus influenzae
;
HIV
;
Humans
;
Hypogonadism
;
Immunization Programs
;
Infant
;
Malaria
;
Measles
;
Meningitis
;
Missions and Missionaries
;
Mitochondrial Diseases
;
Nanoparticles
;
Ophthalmoplegia
;
Poliomyelitis
;
Public Health
;
Public-Private Sector Partnerships
;
Respiratory Syncytial Viruses
;
Smallpox Vaccine
;
Vaccines
;
Viruses
9.Male involvement in maternal health.
Rovea Ernazelle G. AUSTRIA ; Carl Abelardo T. ANTONIO
Philippine Journal of Health Research and Development 2017;21(2):25-32
Traditionally, programs related to maternal health are regarded as purely a woman's domain. Nevertheless, the role of the male as the decision maker in the household gave way to the recognition of the male's role in maternal and reproductive health. This paper aimed to provide a review on male involvement strategies and their impact on maternal health based on related studies, discuss the strategies in the Philippine context and suggest interventions given the current state of the Philippine health care system. These strategies utilize the decision-making role of the male by positing itself on the reproductive, sexual and maternal health aspects encompassing important factors, such as birth spacing, first pregnancy, family planning, utilization of skilled birth attendants (SBAs), and delivery in health facilities, antenatal and postpartum care and nutrition. However, negative repercussions include stigmatization of single mothers and reinforcement of the notion of a man's control over a woman's body. Given the current state of the Philippine health care system, the suggested interventions try to veer away from it as much as possible. These include integration of the male involvement strategy into the Pantawid Pamilyang Pilipino Program (4Ps), coursing it through a public-private partnership (PPP) and non-government organizations (NGOs), involvement of educational institutions, strengthening of the health service delivery at the grassroots level, reinforcement of existing laws, and research on its institutionalization. With carefully-planned strategies that recognize existing gender norms and other sociocultural factors, male involvement in maternal health could be a possible catalyst in decreasing the Philippine maternal mortality rate (MMR).
Human ; Male ; Female ; Pregnancy ; Maternal Mortality ; Reproductive Health ; Birth Intervals ; Family Planning Services ; Public-private Sector Partnerships ; Stereotyping ; Maternal Health ; Mothers ; Postnatal Care ; Parturition ; Family Characteristics ; Gender Identity ; Delivery, Obstetric ; Decision Making ; Institutionalization ; Health Facilities